Back to main ScienceConsult page

Publications from Dr. Nico van Belzen

Patent Humanized lactoferrin and uses thereof US2003/0229011 A1

Highlighted publications

Achieving sustainable production of milk, Volume 1, 2017

Achieving sustainable production of milk, Volume 2, 2017

World Dairy Situation (CIHEAM), December 2015

Editorials

Editorial IDF Newsbrief, June 2017

Editorial IDF Newsbrief, May 2017

Editorial IDF Newsbrief, March 2017

Editorial IDF Newsbrief, January 2017

Editorial IDF Newsbrief, November 2016

Editorial IDF Newsbrief, October 2016

Editorial IDF Newsbrief, July 2016

Editorial IDF Newsbrief, March 2016

Editorial IDF Newsbrief, November 2015

Editorial IDF Newsbrief, September 2015

Editorial IDF Newsbrief, June 2015

Editorial IDF Newsbrief, March 2015

Editorial IDF Newsbrief, December 2014

Editorial IDF Newsbrief, October 2014

Editorial IDF Newsbrief, July 2014

Editorial IDF Newsbrief, May 2014

Editorial IDF Newsbrief, February 2014

Editorial IDF Newsbrief, December 2013

Editorial IDF Newsbrief, October 2013

Editorial IDF Newsbrief, September 2013

Editorial IDF Newsbrief, July 2013

Editorial IDF Newsbrief, June 2013

Editorial IDF Newsbrief, April 2013

Editorial IDF Newsbrief, March 2013

Editorial IDF Newsbrief, January 2013

Editorial IDF Newsbrief, December 2012

Editorial IDF Newsbrief, September 2012

Editorial ILSI Europe Newsletter, December 2011

Editorial ILSI Europe Newsletter, September 2011

Editorial ILSI Europe Newsletter, June 2011

Editorial ILSI Europe Newsletter, February 2011

Editorial ILSI Europe Newsletter, October 2010

Article in ENLP Newsletter, 2009

Foreword ILSI Europe 20th anniversary brochure, 2006

Article in ILSI Japan Newsletter, 2006

Scientific publications

Corthésy-Theulaz I, den Dunnen JT, Ferré P, Geurts JM, Müller M, van Belzen N, van Ommen B. Nutrigenomics: the impact of biomics technology on nutrition research. Ann Nutr Metab. 2005 Nov-Dec;49(6):355-65

Kwa MS, van Schaik IN, De Jonge RR, Brand A, Kalaydjieva L, van Belzen N, Vermeulen M, Baas F. Autoimmunoreactivity to Schwann cells in patients with inflammatory neuropathies Brain. 2003 Feb;126(Pt 2):361-75

de Waard R, van Belzen N. The anti-carcinogenic potential of lactoferrin. Agro Food Industry Hi Tech 2003 14(2): 35-39

Lachat P, Shaw P, Gebhard S, van Belzen N, Chaubert P, Bosman FT. Expression of NDRG1, a differentiation-related gene, in human tissues. Histochem Cell Biol. 2002 Nov;118(5):399-408

van Belzen N. The role of lactoferrin in cancer prevention. Sciences des Aliments 2002 22:461-8

Witte D, Nimmagudda R, van Belzen N. Natural bioactive peptides for stimulation of the immune system and protection against risk factors for cardiovascular disease Nutraceuticals Now 2001

Brown L, Nimmagudda R, Loftus M, Miller G, van Belzen N, Clarke D, Braun S. Identification of novel anti-oxidant potential in peptide hydrolysates using cell-based models of human metabolism JANA 2000; 3(2):26-31

Hoogeveen-Westerveld M, Hupkes PE, Doekharan D, Dorssers LC, van't Veer MB, van Belzen N. Rearranged immunoglobulin light chain genes as minimal residual disease markers in intermediate- and high-grade malignant B cell non-Hodgkin's lymphoma. Leukemia. 1998 Nov;12(11):1810-6

van Belzen N, Dinjens WN, Eussen BH, Bosman FT. Expression of differentiation-related genes in colorectal cancer: possible implications for prognosis. Histol Histopathol. 1998 Oct;13(4):1233-42

van Belzen N, Hupkes PE, Doekharan D, Hoogeveen-Westerveld M, Dorssers LC, van't Veer MB. Detection of minimal disease using rearranged immunoglobulin heavy chain genes from intermediate- and high-grade malignant B cell non-Hodgkins lymphoma. Leukemia. 1997 Oct;11(10):1742-52

van Belzen N, Dinjens WN, Diesveld MP, Groen NA, van der Made AC, Nozawa Y, Vlietstra R, Trapman J, Bosman FT. A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms. Lab Invest. 1997 Jul;77(1):85-92

Nozawa Y, Van Belzen N, Van der Made AC, Dinjens WN, Bosman FT. Expression of nucleophosmin/B23 in normal and neoplastic colorectal mucosa. J Pathol. 1996 Jan;178(1):48-52

van Belzen N, Diesveld MP, van der Made AC, Nozawa Y, Dinjens WN, Vlietstra R, Trapman J, Bosman FT. Identification of mRNAs that show modulated expression during colon carcinoma cell differentiation Eur J Biochem. 1995 Dec 15;234(3):843-8

Rijken PJ, de Groot RP, van Belzen N, de Laat SW, Boonstra J, Verkleij AJ. Inhibition of EGF-induced signal transduction by microgravity is independent of EGF receptor redistribution in the plasma membrane of human A431 cells. Exp Cell Res. 1993 Feb;204(2):373-7

van Belzen N, Verkleij AJ, Boonstra J. Visualization and quantitative analysis of epidermal growth factor (EGF) receptors at electron microscopical level. Prog Histochem Cytochem. 1992;26(1-4):39-48

Boonstra J, van Bergen en Henegouwen PM, van Belzen N, Rijken PJ, Verkleij AJ. Immunogold labelling in combination with cryoultramicrotomy, freeze-etching, and label-fracture. J Microsc. 1991 Jan;161(Pt 1):135-47

van Belzen N, Rijken PJ, Verkleij AJ, Boonstra J. Sulfhydryl reagents alter epidermal growth factor receptor affinity and association with the cytoskeleton. J Recept Res. 1991;11(6):919-40

van Belzen N, Spaargaren M, Verkleij AJ, Boonstra J. Interaction of epidermal growth factor receptors with the cytoskeleton is related to receptor clustering. J Cell Physiol. 1990 Nov;145(2):365-75

van Belzen N, Rijken PJ, Hage WJ, de Laat SW, Verkleij AJ, Boonstra J. Direct visualization and quantitative analysis of epidermal growth factor-induced receptor clustering. J Cell Physiol. 1988 Mar;134(3):413-20

van Belzen N, van Hemert F, Destrée OH. Eukaryotic messenger RNA degradation. Bioessays. 1988 Jan;8(1):44

Boonstra J, van Belzen N, van Maurik P, Hage WJ, Blok FJ, Wiegant FA, Verkleij AJ. Immunocytochemical demonstrations of cytoplasmic and cell-surface EGF receptors in A431 cells using cryo-ultramicrotomy, surface replication, freeze-etching and label fracture. J Microsc. 1985 Oct;140(Pt 1):119-29

Back to main ScienceConsult page